SMTL ID : 4ere.1 (1 other biounit)

crystal structure of MDM2 (17-111) in complex with compound 23

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 0R2: [(3R,5R,6S)-1-[(2S)-1-tert-butoxy-1-oxobutan-2-yl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-2-oxopiperidin-3-yl]acetic acid(Non-covalent)

0R2.1: 12 residues within 4Å: Chain A: L.39, F.40, G.43, I.46, Y.52, F.71, V.78, K.79, H.81, I.84, Y.85 Ligands: SO4.2 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.39, A:F.40, A:F.40, A:I.46, A:V.78, A:V.78, A:I.84 Hydrogen bonds: A:V.78 Salt bridges: A:K.79, A:H.81 pi-Stacking: A:H.81 Halogen bonds: A:H.81

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: H.81 Ligands: 0R2.1 2 PLIP interactions: 2 interactions with chain A Water bridges: A:Y.85 Salt bridges: A:H.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rew, Y. et al., Structure-based design of novel inhibitors of the MDM2-p53 interaction. J.Med.Chem. (2012)

Release Date

2012-05-23

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence